Play the Live Stream or select a Podcast to play
ADVERTISEMENT
Morning Run · Market Watch · 15 Nov 2020 · 10 mins listen
On news that Pfizer and BioNTech could come out with a Covid-19 vaccine as early as September, glovemakers have taken a hit. But overall, will this industry still be able to keep some momentum going? We speak to Stephen Innes, Global Chief Market Strategist at Axi, about Asian glovemakers, trade ties in the wake of RCEP, and the rotation into cyclicals seen in US equity markets.
Related Content
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT